CLOUGH CAPITAL PARTNERS L P - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.

Quarter-by-quarter ownership
CLOUGH CAPITAL PARTNERS L P ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2015$4,532,000
-63.3%
20,400
-67.1%
0.17%
-57.6%
Q1 2015$12,334,000
-26.1%
62,100
-46.7%
0.41%
-31.8%
Q4 2014$16,687,000116,6000.60%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders